Treatment of muscle weakness in neuromuscular disorders

Abstract

Weakness is one of the predominant clinical manifestations of neuromuscular disorders (NMDs), which strongly influences daily life, prognosis, and outcome of affected patients. One of the major therapeutic goals in NMD-patients is to completely resolve muscle weakness. Various treatment options are available and include physical therapy, electrotherapy, diet, drugs, avoidance or withdrawal of muscle-toxic and weakness-inducing agents, detoxification, stem-cell-therapy, plasma-exchange, respiratory therapy, or surgery. Most accessible to treatment is weakness from immune-mediated neuropathies, immune-mediated transmission-disorders, and idiopathic immune myopathies. Areas covered: This manuscript aims to summarize and discuss recent findings and future perspectives concerning the treatment of muscle weakness in NMDs. Data were obtained by a literature search in databases such as PubMed and Current-Contents. Expert commentary: Weakness is most easily treatable in acquired NMDs and in hereditary myopathies and neuropathies beneficial treatment options are also available. Research needs to be encouraged and intensified to further expand the spectrum of treatment options for weakness.

Exploring the psychosocial impact of simple robotic assistive technology on adolescents with neuromuscular disease

“…19 This allowed for the overarching themes to become clear over the course of the study and data saturation was reached. Our coding was teambased and the process consisted of 6 phases: (1) familiarization with the data; (2) initial coding; (3) organizing codes into themes; (4) review of themes; (5) naming and definition of themes; and (6) reporting. 19 Themes were agreed upon within the research team through consensus.…”

“… 1 Muscle weakness is one of the predominant clinical manifestations of NMDs. 5 Neuromuscular diseases do vary in magnitude and intensity, but they carry some common characteristics including (i) muscle weakness, (ii) muscle loss, (iii) movement issues, and (iv) reduced pulmonary function. 6 The above characteristics are progressive and translate into deterioration over time in activities of daily living (ADL) that require finger and arm strength, and in personal mobility.…”

Repeated Low-Level Red-Light Therapy for Controlling Onset and Progression of Myopia-a Review

“…Evidence has indicated that CCO is the primary photo receptor [131], promoting oxidative metabolism [132] and increase ATP production [133], and is probably linked to increased CCO and reduced acrolein expression [134] through the reparative and/or the protective mechanism. In fact, abundant research results supports its potential benefits in retinal diseases [97], stroke [135,136], neurodegeneration [137], neuromuscular disorders [138], hair regrowth [139], memory [140] and mood disorders [141].…”

Near Infrared (NIR) Light Therapy of Eye Diseases: A Review

“…Although the precise mechanism is unknown, there is strong evidence to suggest that cytochrome c oxidase acts as the primary photo-receptors [66], boosting oxidative metabolism [67] and ATP production [18], and is probably linked to increase of cytochrome c oxidase and reduction of acrolein expression [68], driving reparative and protective mechanisms. In fact, abundant research results supports its potential benefits in retinal disease [33], stroke [69,70], neurodegeneration [5], neuromuscular disorders [71], hair regrowth [72], memory [73] and mood disorders [74].…”